Gene-modified T lymphocytes in the setting of hematopoietic cell transplantation: potential benefits and possible risks

Author： Sangiolo Dario   Leuci Valeria   Gallo Susanna   Aglietta Massimo   Piacibello Wanda  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.11, Iss.5, 2011-05, pp. : 655-666

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rituximab in hematopoietic cell transplantation

By Arai Sally   Miklos David B  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 6, 2010-06 ,pp. : 971-982

Informa Healthcare

Access to resources Recommend Favorite

Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation

By Leen Ann M   Tripic Tamara   Rooney Cliona M  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 3, 2010-03 ,pp. : 337-351

Informa Healthcare

Access to resources Recommend Favorite

Requisite considerations for successful adoptive immunotherapy with engineered T-lymphocytes using tumor antigen-specific T-cell receptor gene transfer

By Ochi Toshiki   Fujiwara Hiroshi   Yasukawa Masaki  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 6, 2011-06 ,pp. : 699-713

Informa Healthcare

Access to resources Recommend Favorite

Allogeneic hematopoietic cell transplantation for renal cell carcinoma: ten years after

By Tykodi Scott S   Sandmaier Brenda M   Warren Edus H   Thompson John A  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 6, 2011-06 ,pp. : 763-773

Informa Healthcare

Access to resources Recommend Favorite

Genotoxicity of retroviral hematopoietic stem cell gene therapy

By Trobridge Grant D  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 5, 2011-05 ,pp. : 581-593

Informa Healthcare

Access to resources Recommend Favorite